“Bimekizumab Provides Rapid and Sustained Improvements in Scalp and Nail Outcomes in Patients With Moderate to Severe Plaque Psoriasis: 60 Week Results from a Randomized, Double Blinded, Phase 2b Extension Study”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S34, https://doi.org/10.25251/skin.3.supp.34.